Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-initiating Cells from Lung Adenocarcinoma.
about
Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-initiating Cells from Lung Adenocarcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@en
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@nl
type
label
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@en
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@nl
prefLabel
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@en
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@nl
P2093
P2860
P1476
Targeting USP22 Suppresses Tum ...... ells from Lung Adenocarcinoma.
@en
P2093
Isaac K Nardi
Jinhui Wang
Keqiang Zhang
Melissa Bonner
Rajendra P Pangeni
P2860
P356
10.1158/1541-7786.MCR-18-0042
P577
2018-05-02T00:00:00Z